Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015

被引：0
|
作者：
Osmolovskaya, Yu. F. [1 ]
Zhirov, I. V. [1 ]
Tereshchenko, S. N. [1 ]
机构：
[1] Minist Hlth Russia, AL Myasnikov Inst Clin Cardiol, Dept Myocardial Dis & Heart Failure, Russian Cardiol Res & Prod Complex, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2015年 / 87卷 / 09期
关键词：
aldosterone; mineralocorticoid receptor antagonists; chronic heart failure; PRESERVED EJECTION FRACTION; CHRONIC KIDNEY-DISEASE; SELECTIVE ALDOSTERONE BLOCKER; MILD PATIENTS HOSPITALIZATION; DOUBLE-BLIND; BAY; 94-8862; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; ASSOCIATION HFA; EMPHASIS-HF;
D O I：
10.17116/terarkh201587977-83
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Mineralocorticoid receptor antagonists (MCRA) are part of standard medical therapy for heart failure (HF). The clinical efficacy of MCRA in patients with systolic HF has been proven by randomized clinical trials. The efficacy of this drug group in patients with chronic HF with preserved left ventricular systolic function and the advent and practical introductions of safer new-generation MCRA remain to be answered.
引用
收藏
页码：77 / 83
页数：7
相关论文
共 50 条
  • [41] The mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction
    Ferraz, L. M.
    Martins, J. L.
    Faustino, A.
    Pacheco, A.
    Carvalho, D.
    Carvalho, P.
    Neves, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 20 - 20
  • [42] Non-steroidal mineralocorticoid receptor antagonists in heart failure
    Filippatos, Gerasimos
    Farmakis, Dimitrios
    NATURE REVIEWS CARDIOLOGY, 2023, 20 (10) : 645 - 646
  • [43] Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure
    Vaduganathan, Muthiah
    Ferreira, Joao Pedro
    Rossignol, Patrick
    Neuen, Brendon L.
    Claggett, Brian L.
    Pfeffer, Marc A.
    McMurray, John J., V
    Pitt, Bertram
    Zannad, Faiez
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1586 - 1590
  • [44] The role of endothelin receptor antagonists in the treatment of chronic heart failure
    Kiowski W.
    Sütsch G.
    Current Cardiology Reports, 2001, 3 (3) : 232 - 240
  • [45] AT1-receptor antagonists for the treatment of chronic heart failure
    Baan, J
    CARDIOVASCULAR RESEARCH, 1999, 41 (01) : 14 - 15
  • [46] Treatment of chronic heart failure. A review
    Thery, C
    Asseman, P
    Bauchart, JJ
    Loubeyre, C
    REVUE DE MEDECINE INTERNE, 1996, 17 (02): : 135 - 143
  • [47] Mineralocorticoid receptor antagonists modulate galectin-3 cardiac expression in chronic heart failure
    Sanchez-Mas, J.
    Lax, A.
    Asensio-Lopez, M. C.
    Santarelli, G.
    Abenza, S.
    Caballero, L.
    Perez-Martinez, M. T.
    Fernandez-Del Palacio, M. J.
    Valdes, M.
    Pascual-Figal, D. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S60 - S60
  • [48] Mineralocorticoid receptor antagonists in heart failure: they work better when patients use them
    Greenberg, Barry
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (09) : 1335 - 1337
  • [49] Impacts of mineralocorticoid receptor antagonists on mortality in heart failure patients with beta-blockers
    Kato, N. P.
    Kinugawa, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 232 - 232
  • [50] Discontinuation and reinitiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction
    Landucci, Laura
    Faxen, Ulrika Ljung
    Benson, Lina
    Dahlstrom, Ulf
    Carrero, Juan J.
    Savarese, Gianluigi
    Lund, Lars H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2025, 27 (02) : 219 - 227
12345